E-mail this story
Roche won't extend $6.8 billion bid for San Diego's Illumina
Swiss drugmaker Roche will not extend its hostile $6.8-billion bid for Illumina Inc. after the San Diego biotech company’s shareholders rejected Roche’s attempts to appoint new board members.
By Tiffany Hsu
April 18, 2012